# Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population

Study · id `cardio:ct-nct01556126` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01556126](<https://clinicaltrials.gov/study/NCT01556126>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01556126

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1191 participants.

## Technical summary

Registry record NCT01556126. Allocation not applicable; no masking; primary purpose treatment. Start 2012-02 (actual); primary completion 2014-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1191 participants (enrolled count; ClinicalTrials.gov record NCT01556126, source copy `cardio:ctgov-nct01556126-2021-07-20`, retrieved 2026-10-26)
- Started: 2012-02 (actual) (ClinicalTrials.gov record NCT01556126, source copy `cardio:ctgov-nct01556126-2021-07-20`, retrieved 2026-10-26)
- Primary completion: 2014-07 (actual) (ClinicalTrials.gov record NCT01556126, source copy `cardio:ctgov-nct01556126-2021-07-20`, retrieved 2026-10-26)
- Completion: 2018-12 (actual) (ClinicalTrials.gov record NCT01556126, source copy `cardio:ctgov-nct01556126-2021-07-20`, retrieved 2026-10-26)
- Countries: Austria; Belgium; Italy; Netherlands; Norway; Poland (ClinicalTrials.gov record NCT01556126, source copy `cardio:ctgov-nct01556126-2021-07-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01556126-2021-07-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population
- Acronym: PARTICIPATE
- Condition: Stable Angina
- Condition: Unstable Angina
- Condition: Acute Myocardial Infarction
- Intervention (Device): Amphilimus Eluting Stent (CRE8)
- Lead sponsor: CID - Carbostent & Implantable Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)

## Provenance

Content hash: 77804d872f2c14a53ad478bba095837792cd96427320ba38db1523b4e1c7e6af
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
